Skip to main content

Applied Genetic Technology Tumbles 32% On Eye Study Problems

Applied Genetic Technology tumbled 32% after reporting problems with its gene trial in treating patients with a rare eye disorder.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.